These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 18713448)

  • 1. Pooling overdispersed binomial data to estimate event rate.
    Young-Xu Y; Chan KA
    BMC Med Res Methodol; 2008 Aug; 8():58. PubMed ID: 18713448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal beta-binomial modeling using GEE for overdispersed binomial data.
    Wu H; Zhang Y; Long JD
    Stat Med; 2017 Mar; 36(6):1029-1040. PubMed ID: 27917499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Finite mixture models for proportions.
    Brooks SP; Morgan BJ; Ridout MS; Pack SE
    Biometrics; 1997 Sep; 53(3):1097-115. PubMed ID: 9333342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral antifungal medication for toenail onychomycosis.
    Kreijkamp-Kaspers S; Hawke K; Guo L; Kerin G; Bell-Syer SE; Magin P; Bell-Syer SV; van Driel ML
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD010031. PubMed ID: 28707751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute generalized exanthematous pustulosis induced by terbinafine.
    Taberner R; Puig L; Gilaberte M; Alomar A
    Eur J Dermatol; 2003; 13(3):313-4. PubMed ID: 12805000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutropenia and pancytopenia associated with oral terbinafine.
    Kovacs MJ; Alshammari S; Guenther L; Bourcier M
    J Am Acad Dermatol; 1994 Nov; 31(5 Pt 1):806. PubMed ID: 7929931
    [No Abstract]   [Full Text] [Related]  

  • 7. Thrombocytopenia associated with oral terbinafine.
    Grunwald MH
    Int J Dermatol; 1998 Aug; 37(8):634. PubMed ID: 9732018
    [No Abstract]   [Full Text] [Related]  

  • 8. Onychomycosis treated with a short course of oral terbinafine.
    Galimberti R; Kowalczuk A; Flores V; Squiquera L
    Int J Dermatol; 1996 May; 35(5):374-5. PubMed ID: 8734666
    [No Abstract]   [Full Text] [Related]  

  • 9. Oral terbinafine and erythema multiforme.
    Todd P; Halpern S; Munro DD
    Clin Exp Dermatol; 1995 May; 20(3):247-8. PubMed ID: 7671425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversible agranulocytosis associated with oral terbinafine in a pediatric patient.
    Aguilar C; Mueller KK
    J Am Acad Dermatol; 2001 Oct; 45(4):632-4. PubMed ID: 11568763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inappropriate use of oral terbinafine in family practice.
    Wilcock M; Hartley J; Gould D
    Pharm World Sci; 2003 Feb; 25(1):25-6. PubMed ID: 12661473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Twelve weeks of continuous oral therapy for toenail onychomycosis caused by dermatophytes: a double-blind comparative trial of terbinafine 250 mg/day versus itraconazole 200 mg/day.
    De Backer M; De Vroey C; Lesaffre E; Scheys I; De Keyser P
    J Am Acad Dermatol; 1998 May; 38(5 Pt 3):S57-63. PubMed ID: 9594939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The treatment of dermatophytosis: safety considerations.
    Smith EB
    J Am Acad Dermatol; 2000 Nov; 43(5 Suppl):S113-9. PubMed ID: 11044286
    [No Abstract]   [Full Text] [Related]  

  • 14. [Rhabdomyolisis and terbinafine].
    Gallego Peris A; Sanfélix Gimeno G; Palop Larrea V; Sanfélix Genovés J
    Med Clin (Barc); 2006 Nov; 127(20):799. PubMed ID: 17198674
    [No Abstract]   [Full Text] [Related]  

  • 15. On the EM algorithm for overdispersed count data.
    McLachlan GJ
    Stat Methods Med Res; 1997 Mar; 6(1):76-98. PubMed ID: 9185291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Terbinafine and warfarin interaction].
    Schmutz JL; Barbaud A; Tréchot P
    Ann Dermatol Venereol; 1999 May; 126(5):463. PubMed ID: 10434116
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparable efficacy and safety of various topical formulations of terbinafine in tinea pedis irrespective of the treatment regimen: results of a meta-analysis.
    Korting HC; Kiencke P; Nelles S; Rychlik R
    Am J Clin Dermatol; 2007; 8(6):357-64. PubMed ID: 18039018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of dermatophyte onychomycosis with three pulses of terbinafine (500 mg day for a week).
    Takahata Y; Hiruma M; Shiraki Y; Tokuhisa Y; Sugita T; Muto M
    Mycoses; 2009 Jan; 52(1):72-6. PubMed ID: 18444971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequentist performance of Bayesian confidence intervals for comparing proportions in 2 x 2 contingency tables.
    Agresti A; Min Y
    Biometrics; 2005 Jun; 61(2):515-23. PubMed ID: 16011699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent updates in oral terbinafine: its use in onychomycosis and tinea capitis in the US.
    Van Duyn Graham L; Elewski BE
    Mycoses; 2011 Nov; 54(6):e679-85. PubMed ID: 21668517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.